Published in Bull World Health Organ on January 01, 1999
Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer (2006) 1.94
Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies. Sex Transm Infect (2007) 1.29
Hospital-based evaluation of two rapid human immunodeficiency virus antibody screening tests. J Clin Microbiol (2000) 1.19
Review of STI and HIV epidemiological data from 1990 to 2001 in urban Burkina Faso: implications for STI and HIV control. Sex Transm Infect (2004) 1.02
Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa. BMC Public Health (2011) 1.00
HIV prevention and care services for female sex workers: efficacy of a targeted community-based intervention in Burkina Faso. J Int AIDS Soc (2015) 0.88
Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus. Clin Vaccine Immunol (2007) 0.87
Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174. BMC Infect Dis (2012) 0.83
Evaluation of HIV antigen/antibody combination ELISAs for diagnosis of HIV infection in Dar Es Salaam, Tanzania. Pan Afr Med J (2015) 0.75
Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa. J Clin Microbiol (2010) 0.75
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (1985) 13.47
Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science (1985) 8.53
Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ (1992) 5.66
Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science (1985) 3.81
Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates. JAMA (1992) 3.75
Epidemic of fatal encephalopathy in preschool children in Burkina Faso and consumption of unripe ackee (Blighia sapida) fruit. Lancet (1999) 2.98
Sexual and reproductive life of women informed of their HIV seropositivity: a prospective cohort study in Burkina Faso. J Acquir Immune Defic Syndr (2001) 2.86
Human immunodeficiency virus infection in urban Rwanda. Demographic and behavioral correlates in a representative sample of childbearing women. JAMA (1991) 2.85
Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III. Lancet (1985) 2.84
Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet (1985) 2.77
Postnatal transmission of HIV from mother to child. Lancet (1987) 2.60
HTLV-I/II antibodies in French blood donors. Lancet (1990) 2.54
Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet (1986) 2.48
Evidence of behaviour change following a hygiene promotion programme in Burkina Faso. Bull World Health Organ (2001) 2.47
Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis (1999) 2.32
Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet (1981) 2.31
Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health (1993) 2.16
Acquired immunodeficiency syndrome in Rwanda. Lancet (1984) 2.05
Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med (1992) 2.03
CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients? J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.99
Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer (2006) 1.94
New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). Science (1986) 1.91
Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology (1997) 1.79
Living with HIV: women's experience in Burkina Faso, West Africa. AIDS Care (2001) 1.73
Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Ann Neurol (1987) 1.63
Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature (1984) 1.63
Antibody to HTLV-III in blood donors in central Africa. Lancet (1985) 1.61
[The HIV epidemic in Burkina Faso: current status and the knowledge level of the population about AIDS, 1994-1995]. Rev Epidemiol Sante Publique (1998) 1.61
A cohort study of factors associated with failure to return for HIV post-test counselling in pregnant women: Kigali, Rwanda, 1992-1993. AIDS (1996) 1.60
Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa. Science (1987) 1.58
Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Prog Med Virol (1981) 1.45
Male circumcision, sexually transmitted disease, and risk of HIV. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.45
Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. Pregnancy and HIV Study Group. AIDS (1998) 1.42
Infant feeding policy and practice in the presence of HIV-1 infection. AIDS (1995) 1.39
Heterosexual promiscuity among African patients with AIDS. N Engl J Med (1985) 1.38
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis (2008) 1.35
Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory Coast. Lancet (1987) 1.35
Voluntary confidential HIV testing for couples in Kigali, Rwanda. AIDS (1993) 1.35
Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To-Child Transmission of HIV. Health Policy Plan (2000) 1.34
Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics (1993) 1.33
A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome in Africa. Am J Ophthalmol (1985) 1.33
Knowledge, attitudes, and perceived risk of AIDS among urban Rwandan women: relationship to HIV infection and behavior change. AIDS (1991) 1.32
Should screening of genital infections be part of antenatal care in areas of high HIV prevalence? A prospective cohort study from Kigali, Rwanda, 1992-1993. The Pregnancy and HIV (EGE) Group. Genitourin Med (1995) 1.31
Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual Africans. JAMA (1985) 1.30
Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics (1992) 1.28
Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1992. AIDS (1994) 1.28
Ultrastructural and physicochemical characterization of the hepatitis C virus recovered from the serum of an agammaglobulinemic patient. Arch Virol (1998) 1.28
First molecular epidemiology study of Mycobacterium tuberculosis in Burkina Faso. J Clin Microbiol (2007) 1.27
[Quantitative estimate of the risk of blood donation contamination by infectious agents]. Transfus Clin Biol (2009) 1.21
HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network. AIDS (2000) 1.21
Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients. J Infect Dis (1986) 1.20
Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993. Pediatr Infect Dis J (1996) 1.19
Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations. J Infect Dis (1987) 1.17
Immunogenic nature of a Pol gene product of HTLV-III/LAV. Blood (1987) 1.17
Anaemia during pregnancy in Burkina Faso, west Africa, 1995-96: prevalence and associated factors. DITRAME Study Group. Bull World Health Organ (1999) 1.16
Severe herpes zoster ophthalmicus in young African adults: a marker for HTLV-III seropositivity. Br J Ophthalmol (1987) 1.14
Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses (1991) 1.13
Enzyme-linked oligosorbent assay for detection of polymerase chain reaction-amplified human immunodeficiency virus type 1. J Clin Microbiol (1993) 1.13
Active immunization against hepatitis B in an area of high endemicity. Part I: Field design. Prog Med Virol (1981) 1.12
Chronic diarrhea among adults in Kigali, Rwanda: association with bacterial enteropathogens, rectocolonic inflammation, and human immunodeficiency virus infection. Clin Infect Dis (1995) 1.12
Immune response in neonates to hepatitis B vaccine. Lancet (1982) 1.11
Evaluation of a quantitative determination of CD4 and CD8 molecules as an alternative to CD4+ and CD8+ T lymphocyte counts in Africans. Trop Med Int Health (1999) 1.10
Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization. AIDS Res Hum Retroviruses (1998) 1.09
HIV type 1 diversity in northern Paris, France. AIDS Res Hum Retroviruses (1996) 1.09
Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Sex Transm Infect (2008) 1.08
Identification of the glycoprotein 41(TM) cytoplasmic tail domains of human immunodeficiency virus type 1 that interact with Pr55Gag particles. AIDS Res Hum Retroviruses (2000) 1.07
Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis (1992) 1.07
[Lack of knowledge among blood donors in Burkina Faso (West Africa); potential obstacle to transfusion security]. Transfus Clin Biol (2008) 1.05
HIV infection as a risk factor for septic arthritis. Br J Rheumatol (1997) 1.05
Ophthalmic manifestations of infections with Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol (1993) 1.05
Pulmonary tuberculosis in Kigali, Rwanda. Impact of human immunodeficiency virus infection on clinical and radiographic presentation. Am Rev Respir Dis (1992) 1.04
Low birthweight in infants born to African HIV-infected women: relationship with maternal body weight during pregnancy: Pregnancy and HIV Study Group (EGE). J Trop Pediatr (1999) 1.03
Hepatitis-B vaccination in the elderly. J Infect Dis (1984) 1.03
Zidovudine to decrease mother-to-child transmission of HIV-1: is it good for developing countries? AIDS (1995) 1.03
Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission. J Clin Microbiol (1998) 1.03
Review of STI and HIV epidemiological data from 1990 to 2001 in urban Burkina Faso: implications for STI and HIV control. Sex Transm Infect (2004) 1.02
The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs. J Infect Dis (1998) 1.00
Four years of natural history of HIV-1 infection in african women: a prospective cohort study in Kigali (Rwanda), 1988-1993. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.00
HIV seropositivity and cholera in refugee children from Rwanda. AIDS (1995) 0.99
[HBs antigen carrier state in pregnant women in Bobo Dioulasso (Burkina Faso)]. Dakar Med (2000) 0.99
Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations. J Clin Microbiol (1993) 0.99
Preliminary results from the new HIV surveillance system in France. Euro Surveill (2004) 0.98
HIV-2 antibodies in African with spastic paraplegia. Lancet (1988) 0.97
Pattern of sexually transmitted diseases among pregnant women in Burkina Faso, west Africa: potential for a clinical management based on simple approaches. Genitourin Med (1997) 0.97